“… NALBANT et al ., 2022, Turkey. ( 19 ) | Cohort / 9 | 313 - 220 cases* - 93 controls 2 | COVID-19 infection | - No significant difference |
AMOROSO et al ., 2021, Italy. ( 20 ) | Cohort / 8 | 40,904 - 219 cases** - 40,685 controls 2 | COVID-19 infection | - Group A was more prevalent in COVID patients compared to controls |
MUÑOZ-CULLA et al ., 2021, Basque. |
…”